Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Cancer    crawled date : 2022 - 10 - 05    save search

Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-10-05 (Crawled : 23:00) - biospace.com/
BCEL P | $0.0761 0.0% 350K twitter stocktwits trandingview |
Health Technology
| | O: -1.98% H: 7.51% C: 5.78%

immunotherapy meeting cancer
Navidea Biopharmaceuticals Announces Acceptance of Abstract for Presentation at Upcoming Society for Immunotherapy of Cancer Annual Meeting
Published: 2022-10-05 (Crawled : 23:00) - biospace.com/
NAVB | $0.035 50.69% 15K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 1.54% C: -3.85%

immunotherapy meeting presentation cancer
Shattuck Labs to Present Updated Preclinical Data on Gamma Delta T Cell Engager (GADLEN) Platform Candidates at the Society for Immunotherapy of Cancer (SITC) Annual Meeting November 8-12
Published: 2022-10-05 (Crawled : 21:00) - globenewswire.com
STTK | $9.58 -5.43% -5.74% 420K twitter stocktwits trandingview |
Health Technology
| | O: 3.1% H: 0.0% C: -2.02%

preclinical immunotherapy meeting cancer platform
Regen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naïve T Cells to Kill Cancer
Published: 2022-10-05 (Crawled : 19:00) - prnewswire.com
RGBP | $0.7 5.69% 11K twitter stocktwits trandingview |
Manufacturing
| | O: 1.54% H: 6.06% C: -1.52%

patent car-t cancer
Rush Enterprises supports the Breast Cancer Research Foundation; Company launches limited-edition pink mudflaps in honor of Breast Cancer Awareness Month
Published: 2022-10-05 (Crawled : 18:00) - globenewswire.com
RUSHB | $46.5 2.63% 2.56% 18K twitter stocktwits trandingview |
Distribution Services
| | O: -0.84% H: 0.06% C: 0.06%
RUSHA | $48.71 1.56% 1.54% 300K twitter stocktwits trandingview |
Distribution Services
| | O: -0.85% H: 1.38% C: 1.29%

research breast cancer
Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
ACET | $1.95 -3.7% -3.85% 730K twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 1.19% C: 0.2%

preclinical immunotherapy meeting cancer
Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K twitter stocktwits trandingview |
Health Technology
| | O: 0.77% H: 0.76% C: -3.05%

biotech immunotherapy meeting cancer
Leap Therapeutics to Present Updated Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab and Preclinical Data in Colorectal Cancer Models at the SITC Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
LPTX | $2.81 -5.07% -5.34% 200K twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 0.39% C: -2.49%
BGNE | $129.51 -1.86% -1.89% 300K twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.08% C: -0.29%

dkn-01 preclinical meeting therapeutics plus leap cancer study
Poseida Therapeutics to Present Trial in Progress Poster for Phase 1 P-MUC1C-ALLO1 Study at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2022-10-05 (Crawled : 17:00) - biospace.com/
PSTX | $2.02 1.0% 0.99% 640K twitter stocktwits trandingview |
Health Technology
| | O: -1.14% H: 8.38% C: 7.51%

immunotherapy meeting trial therapeutics cancer study phase 1
ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-10-05 (Crawled : 13:00) - ir.chemocentryx.com
CCXI | $51.99 -0.04% twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.15% C: 0.14%

ccx559 immunotherapy meeting cancer
AnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trials
Published: 2022-10-05 (Crawled : 13:00) - ir.anaptysbio.com
ANAB | $19.865 0.18% 0.18% 290K twitter stocktwits trandingview |
Health Technology
| | O: 1.97% H: 0.0% C: -0.76%

lung trials positive cancer
TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting
Published: 2022-10-05 (Crawled : 13:00) - globenewswire.com
TCRX | News 0 d | $6.79 -1.88% -1.91% 280K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 3.1% H: 0.33% C: -4.01%

immunotherapy meeting therapeutics cancer
Sensei Biotherapeutics to Present New Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - investors.senseibio.com
SNSE | $1.03 4.79% 4.57% 24K twitter stocktwits trandingview |
| | O: 0.0% H: 2.4% C: -2.4%

preclinical immunotherapy meeting cancer
Ikena Oncology to Present Initial Phase 1a/b Results from Novel AHR Inhibition Program at the 2022 Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
IKNA | $1.3 3.18% 3.08% 330K twitter stocktwits trandingview |
Manufacturing
| | O: -4.86% H: 5.11% C: -5.11%

immunotherapy meeting program cancer
Lyell Immunopharma to Present Preclinical Data Highlighting New T-Cell Reprogramming Technologies and its Growing Pipeline at 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
LYEL | $2.24 -3.86% -4.02% 1.1M twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.88% H: 2.15% C: 0.51%

preclinical immunotherapy meeting growing t-cell cancer
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
CRSP M | $55.04 -1.99% -2.03% 1.8M twitter stocktwits trandingview |
Health Technology
| | O: -1.87% H: 0.87% C: 0.29%

crispr immunotherapy meeting therapeutics cancer
Medicenna Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
MDNA | $0.157 -0.32% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -2.41% H: 10.14% C: 8.37%

immunotherapy meeting cancer
NextCure to Give Two Presentations at Society for Immunotherapy of Cancer Annual Meeting
Published: 2022-10-05 (Crawled : 12:20) - globenewswire.com
NXTC | $1.67 6.37% 5.99% 62K twitter stocktwits trandingview |
Health Technology
| | O: 3.31% H: 0.0% C: -3.84%

immunotherapy meeting cancer
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.